Skip to main content
CDC Website

HIV and AIDS

Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use.

Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)

This notice of funding opportunity (NOFO) encourages revision applications from currently funded NIH Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to expand the role of the CFARs and D-CFARs to include additional support and infrastructure for outreach and research related to HIV and HIV-related health disparities in the United States and globally. The goal of the NOFO is aimed towards diversifying and supporting the next generation of HIV/AIDS investigators, and engaging and mentoring these investigators in high-priority HIV/AIDS research.

What motivated you to join the Let’s Stop HIV Together campaign?

On November 30, NASTAD hosted a webinar, “Program Evaluation – Just the Basics.”This webinar provided a basic overview of program evaluation. It covered the importance of evaluation on the success of a program, common misconceptions about evaluation, and different kinds of evaluation commonly used by HIV prevention programs. 

Topics discussed were the general principles and key components of program evaluation processes using CDC’s framework for program evaluation, practical examples of evaluation tools including SMARTIE objectives, and logic models.